[Video Rountable] Is The Government Spying On Paranoid Schizophrenics Enough?

...

Synergetics Closes Plant to Increase Operational Efficiencies

Synergetics USA will close its Philadelphia plant and merge the operations and production of generator products to its O’Fallon, MO plant. The move is part of the company’s overall strategy to continue improving product and component integration in an effort to increase operational efficiencies. The...

CMS Decision Creates Huge New Opportunity for INRatio

The human body has a complex mechanism that causes blood to clot if a wound occurs – a desirable response under normal circumstances. But under certain clinical conditions, known as thrombotic disorders, this same mechanism can cause an unwanted clot or “thrombus” and is potentially life...

Encision Strives to Enlarge Customer Base; Will Investors Get Burned?

Boulder, CO-based Encision offers electrosurgical devices and laparoscopic instruments that incorporate active electrode monitoring or AEM. The technology continuously shields and monitors monopolar laparoscopic instruments during surgery to prevent stray energy burns, but is otherwise comparable to...

Spiration Raises Funds to Support Commercialization in Europe, Clinical Trials in U.S.

Redmond WA-based Spiration, developer of the IBV Valve System (IBV), has raised $18.5 million in a series G round of equity funding led by existing investor Versant Ventures. Spiration has raised $97 million since 1999. IBV was developed as a treatment alternative for emphysema patients who do not respond to...

[Video Profile] Interview with Craig Davenport, President & CEO of Endocare

Each year over 234,000 new cases of prostate cancer are diagnosed in the U.S. Treatment options include surgery, radiation therapy, hormone therapy, “watchful waiting” and cryotherapy. Treatment depends on factors including the patient’s age, the stage of the cancer and the presence of other...

Minrad Parter RxElite Awarded Anesthetic Gas Contract by Premier, Inc.

RxElite announced the signing of a multi-source contract award with Premier, Inc. for the sale of RxElite’s anesthetic gas products, Sevoflurane and Isoflurane. RxElite was awarded this multi-source contract listing for all classes of trade and the company’s anesthetic gas products are...

E-Z-EM to Strengthen Bracco’s Diagnostic Imaging Business; Merger to Close in April

E-Z-EM, a diversified provider of contrast agents for gastrointestinal radiology, will be acquired by Bracco Diagnostics, the U.S.-based subsidiary of Bracco Imaging S.p.A., for $241 million in cash. The merger is expected to close sometime in early April. Under the terms of the agreement, EZ stockholders...